BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, December 23, 2024
See today's BioWorld MedTech
Home
» Olympus in $370M buy of Taewoong to expand in gastrointestinal endotherapy field
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Olympus in $370M buy of Taewoong to expand in gastrointestinal endotherapy field
Feb. 27, 2023
By
Doris Yu
No Comments
Olympus Corp. has acquired Taewoong Medical Co. Ltd. in a $370 million deal to expand its gastrointestinal (GI) endotherapy product portfolio.
BioWorld MedTech
Deals and M&A
Asia-Pacific
